-+ 0.00%
-+ 0.00%
-+ 0.00%

Johnson & Johnson Submits EMA Application for Teclistamab and Daratumumab Combo in Relapsed Multiple Myeloma

路透·01/06/2026 13:07:56

登錄查看新聞詳情